‹ All Posts
Saurabh Tyagi--Clovek,Advisory

29th Apr 2025 · SEBI-Registered Analyst

AMBUJACEM
Results Update

AMBUJACEM
Revenue from operations for 3 months ended 31/03/2025: ₹9,802.47 Crore, YoY growth: 11.57% Profit after tax for 3 months ended 31/03/2025: ₹1,521.21 Crore. Have reached 100 MTPA capacity, is the 9th largest globally, with revenue at Rs 35,045 Cr, and acquired Orient Cement. Future plans aim for 140 MTPA by 2028, emphasizing sustainability initiatives.

#StockInNews#WatchOutFor#FundamentalViews#TrendingSectors#EquityResearch
163 likes·19 comments